Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methadone Maintenance & HIV Risk in Ukraine
NCT00351026Phase 3Completed
- Sponsor
- University of Pennsylvania
- Start
- Jun 2008
- Primary completion
- Oct 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label trial of methadone in opioid use disorder (OUD) (2 arms), sponsored by University of Pennsylvania. Primary endpoints: Acceptability and compliance with a 3-month course of methadone maintenance, Reduction in opioid use at 3 months and 1 more. Started Jun 2008; status: completed.
02
Drugs
methadone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00351026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00351026.